The fungal microbiome and its role in bronchiectasis

S. Chotirmall (Singapore, Singapore)

Source: International Congress 2019 – State of the art session: Respiratory infections
Session: State of the art session: Respiratory infections
Session type: Symposium
Number: 1541
Disease area: Respiratory infections

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Chotirmall (Singapore, Singapore). The fungal microbiome and its role in bronchiectasis. International Congress 2019 – State of the art session: Respiratory infections

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The microbiome in bronchiectasis
Source: ERS Lung Science Conference 2019
Year: 2019

The bronchiectasis microbiome
Source: Eur Respir Monogr 2018; 81: 82-98
Year: 2018


The pulmonary bacterial and fungal microbiota in sarcoidosis patients.
Source: Virtual Congress 2021 – Better understanding of sarcoidosis: new keys
Year: 2021



The role of pathogenic bacterial colonisation in neutrophilic airways inflammation in severe asthma
Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma
Year: 2009

The role of the microbiome in the clinical management of respiratory infections
Source: International Congress 2016 – Respiratory infections in high-income countries: old challenges and new threats
Year: 2016


The consequences of microbiome and pathogen dynamics for chronic lung diseases
Source: Annual Congress 2012 - The bacterial microbiota: implications for health and disease - joint session with the World Allergy Organisation
Year: 2012


The microbiome in IPF
Source: International Congress 2014 – ERS/NEJM joint lunchtime session "The changing landscape of idiopathic pulmonary fibrosis (IPF)"
Year: 2014



The difference of airway microbiota between nontuberculous mycobacteria lung disease and bronchiectasis
Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria
Year: 2020


The role of bacterial infections in COPD exacerbations
Source: Eur Respir J 2005; 26: Suppl. 49, 298s
Year: 2005

Influence of the lung microbiome on antibiotic susceptibility of cystic fibrosis pathogens
Source: Eur Respir Rev, 28 (152) 190041; 10.1183/16000617.0041-2019
Year: 2019



The lung microbiome in obstructive airways disease: potential pathogenetic roles
Source: Eur Respir Monogr 2019; 83: 140-157
Year: 2019


Immunometabolic markers and the sputum microbiome in bronchiectasis
Source: Virtual Congress 2021 – Bronchiectasis heterogeneity: assessing the endotypes
Year: 2021



A molecular comparison of microbial communities in bronchiectasis and cystic fibrosis
Source: Eur Respir J 2013; 41: 991-993
Year: 2013


The impact of bacterial colonisation on airway inflammation in stable COPD
Source: Annual Congress 2012 - COPD is not a pulmonary disease alone
Year: 2012


Do bacteria have a role in asthma development?
Source: Eur Respir J 2010; 36: 469-471
Year: 2010


The lung microbiome and its effects on respiratory infections
Source: Virtual Congress 2020 – Respiratory infections
Year: 2020


What is bacterial colonisation in COPD?
Source: Eur Respir Monogr 2015; 69: 161-171
Year: 2015


The gut microbiota state in patients with pulmonary tuberculosis.
Source: Virtual Congress 2021 – Immunological and molecular characterisation of tuberculosis disease and infection
Year: 2021